Loading viewer...
investor_presentation
Format: PDF investor_presentation
© 2020 Illumina, Inc. All rights reserved.Illumina to Acquire GRAIL Launching a New Era in Cancer Detection September 21, 2020
© 2020 Illumina, Inc. All rights reserved.Illumina to Acquire GRAIL
Launching a New Era in
Additional Information and Where to Find It
In connection with the proposed transaction, Illumina, Inc. (the “Company”) intends to file with the SEC a registration statement on Form S -4 that will include a preliminary prospectus with respect to the Company’s
common stock and contingent value rights to be issued in the proposed transaction and a consent solicitation statement of GRA IL,Inc. (“Grail”) in connection with the proposed transaction. The Company may also
file other documents with the SEC regarding the proposed transaction. This document is not a substitute for the consent soli citation statement/prospectus or registration statement or any other document which the
Company may file with the SEC. INVESTORS AND SECURITY HOLDERS OF GRAIL ARE URGED TO READ THE REGISTRATION STATEMENT, WHICH W ILLINCLUDE THE CONSENT SOLICITATION
STATEMENT/PROSPECTUS, AND ANY OTHER RELEVANT DOCUMENTS THAT ARE FILED OR WILL BE FILED WITH THE SEC, AS WELL AS ANY AMENDMENT S OR SUPPLEMENTS TO THESE DOCUMENTS, CAREFULLY
AND IN THEIR ENTIRETY BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION ABOUT THE PROPOSED TRANSACTION AND RELATED M ATTERS. Investors and security holders may obtain free
copies of the registration statement on Form S -4 (when available), which will include the consent solicitation statement/prospec tus, and other documents filed with the SEC by the Company through the website
maintained by the SEC at www.sec.gov, through the Company’s Investor Relations page (investor.illumina.com) or by writing to Illumina Investor Relations, 5200 Illumina Way, San Diego, CA 92122.
No Offer or Solicitation
This communication is for informational purposes only and is not intended to and does not constitute an offer to subscribe for, buy or sell, or the solicitation of an offer to subscribe for, buy or sell, or an invitation to
subscribe for, buy or sell any securities or a solicitation of any vote or approval in any jurisdiction, nor shall there be any sale, issuance or transfer of securities in any jurisdiction in which such offer, invitation, sale
or solicitation would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. Nooffer of securities shall be made except by means of a prospectus meeting the
requirements of Section 10 of the Securities Act of 1933, as amended, and otherwise in accordance with applicable law.
Cautionary Notes on Forward- Looking Statements
This communication contains “forward- looking statements” within the meaning of the federal securities laws, including Section 27 A of the Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. In this context, forward -looking statements often address expected future business and financial performance and financial condition, and often contain words such as “expect,”
Preview truncated — download the full document for the complete content.
conference
31 Pages
Atlas Engineered Products AEP Growth Strategy 2022
investor_presentationinvestor_presentation
24 Pages
Atlas Engineered Products